MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-06-2025
BioLife Solutions DSO Ratio 2011-2026 | BLFS
Annual DSO Ratio BioLife Solutions
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 37.9 | 101 | 137 | 47.8 | 50.7 | 71.3 | 56.3 | 33.8 | 53 | 53.2 | 53.2 | 41.2 | 38.7 | 72.4 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 137 | 33.8 | 60.5 |
Quarterly DSO Ratio BioLife Solutions
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 34 | 34.5 | 34.9 | - | 76.8 | 84.8 | 87.9 | - | 99.5 | 89.3 | 77.8 | - | 71.3 | 62.5 | 59.8 | - | 55.8 | 46.4 | 50.6 | - | 64.8 | 73.6 | 50.1 | - | -1.68 K | -2.25 K | -1.65 K | - | -6.46 K | -1.57 K | -1.29 K | - | -428 | -358 | -441 | - | - | - | - | - | 17.9 K | 15.5 K | 10.1 K | - | 10.7 K | 18.2 K | - | - | - | - | 34 | - | 32.6 | 49.9 | 62.6 | - | 69.8 | 80.2 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 18.2 K | -6.46 K | 1.52 K |
DSO Ratio of other stocks in the Medical instruments industry
| Issuer | DSO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Atrion Corporation
ATRI
|
0.0506 | - | - | $ 810 M |  USA |
 |
iRhythm Technologies
IRTC
|
38 | $ 127.33 | 4.07 % | $ 4.08 B | USA |
 |
Repro Med Systems
KRMD
|
52.9 | $ 4.05 | 2.15 % | $ 187 M | USA |
 |
Microbot Medical
MBOT
|
167 | $ 2.17 | -1.14 % | $ 99.4 M |  Israel |
 |
Milestone Scientific
MLSS
|
6.61 | $ 0.32 | 0.62 % | $ 26.3 M | USA |
 |
Luminex Corporation
LMNX
|
58.6 | - | - | $ 1.75 B | USA |
 |
Akers Biosciences, Inc.
AKER
|
9.92 | - | -9.52 % | $ 20.6 M | USA |
 |
Alcon
ALC
|
71 | $ 76.22 | 0.57 % | $ 40.4 B |  Schweiz |
 |
Ekso Bionics Holdings
EKSO
|
207 | $ 10.91 | -2.42 % | $ 26.5 M | USA |
 |
STERIS plc
STE
|
68.6 | $ 222.6 | 0.38 % | $ 21.9 B | USA |
 |
The Cooper Companies
COO
|
68.9 | $ 64.72 | 0.47 % | $ 12.9 B | USA |
 |
Teleflex Incorporated
TFX
|
184 | $ 136.19 | -0.27 % | $ 6.08 B | USA |
 |
Antares Pharma, Inc.
ATRS
|
123 | - | - | $ 955 M | USA |
 |
Cantel Medical Corp.
CMD
|
65.5 | - | -1.18 % | $ 3.4 B | USA |
 |
CRH Medical Corporation
CRHM
|
91.1 | - | - | $ 282 M | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
75.4 | - | -0.05 % | $ 10.3 B | USA |
 |
Varian Medical Systems, Inc.
VAR
|
123 | - | -0.02 % | $ 16.3 B | USA |
 |
Haemonetics Corporation
HAE
|
54.9 | $ 61.38 | 2.42 % | $ 3.09 B | USA |
 |
electroCore
ECOR
|
13.6 | $ 6.1 | -1.3 % | $ 51.7 K | USA |
 |
ICU Medical
ICUI
|
29.7 | $ 123.48 | -1.07 % | $ 3.04 B | USA |
 |
Envista Holdings Corporation
NVST
|
53.2 | $ 26.81 | 0.07 % | $ 4.5 B | USA |
 |
Isoray
ISR
|
173 | - | 0.03 % | $ 108 M | USA |
 |
Intuitive Surgical
ISRG
|
49.9 | $ 476.5 | -1.19 % | $ 170 B | USA |
 |
West Pharmaceutical Services
WST
|
66.9 | $ 302.8 | -1.01 % | $ 21.9 B | USA |
 |
Glaukos Corporation
GKOS
|
44 | $ 122.15 | 0.4 % | $ 5.92 B | USA |
 |
Masimo Corporation
MASI
|
12.7 | $ 178.64 | - | $ 9.52 B | USA |
 |
InfuSystem Holdings
INFU
|
53.6 | $ 10.87 | 5.13 % | $ 224 M | USA |
 |
Merit Medical Systems
MMSI
|
47.4 | $ 67.66 | -1.35 % | $ 4 B | USA |
 |
Utah Medical Products
UTMD
|
154 | $ 67.0 | -0.25 % | $ 217 M | USA |
 |
Pulse Biosciences
PLSE
|
15.9 | $ 22.9 | -0.52 % | $ 1.54 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
64.3 | $ 11.92 | 0.04 % | $ 2.38 B | USA |
 |
Retractable Technologies
RVP
|
74.8 | $ 0.64 | -2.14 % | $ 19.2 M | USA |
 |
Pro-Dex
PDEX
|
83.1 | $ 51.58 | -1.0 % | $ 170 M | USA |
 |
LeMaitre Vascular
LMAT
|
42.9 | $ 115.44 | 1.75 % | $ 2.61 B | USA |
 |
Predictive Oncology
POAI
|
96.5 | - | - | $ 31.1 M | USA |
 |
STAAR Surgical Company
STAA
|
100 | $ 26.36 | 2.69 % | $ 1.31 B | USA |
 |
Stereotaxis
STXS
|
54.5 | $ 1.95 | 0.78 % | $ 177 M | USA |
 |
Baxter International
BAX
|
52.6 | $ 18.23 | 0.39 % | $ 9.35 B | USA |
 |
ResMed
RMD
|
60.7 | $ 221.41 | 0.71 % | $ 32.3 B | USA |
 |
AtriCure
ATRC
|
43.4 | $ 29.44 | 0.55 % | $ 1.41 B | USA |
 |
Harvard Bioscience
HBIO
|
65.2 | $ 6.59 | -4.01 % | $ 293 M | USA |
 |
NeuroMetrix
NURO
|
42.8 | - | 5.05 % | $ 9.02 M | USA |
 |
AngioDynamics
ANGO
|
54 | $ 11.15 | 0.45 % | $ 456 M | USA |
 |
Becton, Dickinson and Company
BDX
|
50.4 | $ 151.43 | -0.45 % | $ 43.6 B | USA |
 |
Nephros
NEPH
|
35.7 | $ 2.98 | 3.83 % | $ 31 M | USA |
 |
OraSure Technologies
OSUR
|
73 | $ 2.96 | -1.33 % | $ 218 M | USA |
 |
Repligen Corporation
RGEN
|
69.4 | $ 118.29 | 0.59 % | $ 6.59 M | USA |